55513-190 : Neulasta 6 mg/.6ml Subcutaneous Injection


NDC: 55513-190
Labeler: Amgen Inc
Product Type: Human Prescription Drug
Drug Name:  Neulasta
Dosage Form: Subcutaneous Injection
Application #: BLA125031
Rev. Date: 


NDC Package Codes:

  • 55513-190-01: 1 BLISTER PACK IN 1 BOX (55513‑190‑01) > 1 SYRINGE IN 1 BLISTER PACK > .6 ML IN 1 SYRINGE

Active Ingredients:

  • Pegfilgrastim

Dosage Strength:

  • 6 mg/.6mL

Pharmaceutical Classes:

  • Granulocyte Colony-Stimulating Factor [CS]
  • Granulocyte-Macrophage Colony-Stimulating Factor [CS]
  • Increased Myeloid Cell Production [PE]
  • Leukocyte Growth Factor [EPC]

Related Products:

Based on records with the same trade name.
  • 55513-192 Neulasta Subcutaneous Kit by Amgen Inc
  • 54868-5229 Neulasta 6 mg/.6ml Subcutaneous Injection by Physicians Total Care, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55513-190 QR Code

< Prev: 55513-164Next: 55513-192 >

Related Discussions:

Neulasta Side Effects
What side effects have others encountered while taking Neulasta? ## I don't have any personal experience with this m... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.